user

Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Followed by Maintenance with Bortezomib and Thalidomide for Initial Treatment of Elderly Multiple Myeloma Patients

被引：0
|
作者：
Palumbo, Antonio [1 ]
Bringhen, Sara [1 ]
Rossi, Davide [2 ]
Ria, Roberto [2 ]
Offidani, Massimo [2 ]
Patriarca, Francesca [2 ]
Nozzoli, Chiara [2 ]
Levi, Anna [2 ]
Guglielmelli, Tommasina [2 ]
Benevolo, Giulia [2 ]
Callea, Vincenzo [2 ]
Olivero, Barbara [2 ]
Morabito, Fortunato [2 ]
Grasso, Mariella [2 ]
Marasca, Roberto [2 ]
Rizzo, Manuela [2 ]
Falcone, Antonietta Pia [2 ]
Gottardi, Daniela [3 ]
Montefusco, Vittorio [2 ]
Musolino, Caterina [2 ]
Zambello, Renato [2 ]
Cangialosi, Clotilde [2 ]
Pietrantuono, Giuseppe [2 ]
Magarotto, Valeria [1 ]
Petrucci, Maria Teresa [2 ]
Musto, Pellegrino [2 ]
Ciccone, Giovannino [4 ,5 ]
Di Raimondo, Francesco [2 ]
Gaidano, Gianluca [2 ]
Boccadoro, Mario [1 ]
机构：
[1] Univ Turin, Div Hematol, AOU San Giovanni Battista, Turin, Italy
[2] GIMEMA, Italian Multiple Myeloma Network, Turin, Italy
[3] ASO Mauriziano, SCDU Ematol & Terapie Cellulari, Turin, Italy
[4] Univ Turin, Canc Epidemiol Unit, Turin, Italy
[5] AOU San Giovanni Battista, CPO Piemonte, Turin, Italy
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：58 / 58
页数：1
相关论文
共 50 条
  • [41] Bortezomib and thalidomide treatment of newly diagnosed patients with multiple myeloma - Efficacy and neurotoxicity.
    Borrello, Ivan
    Ferguson, Anna
    Huff, Carol Ann
    George, Shirley
    Biedryzcki, Barbara
    Cornblath, David
    Chaudhry, Vinay
    [J]. BLOOD, 2006, 108 (11) : 1006A - 1006A
  • [42] Bortezomib, thalidomide, and dexamethasone as induction therapy for patients with symptomatic multiple myeloma
    Kaufman, Jonathan L.
    Gleason, Charise
    Heffner, Leonard
    Lonial, Sagar
    [J]. BLOOD, 2007, 110 (11) : 1055A - 1055A
  • [43] VAMP/ThaCyDex: Velcade® (Bortezomib), Adriamycin, Melphalan and Prednisone Alternating with Thalidomide, Cyclophosphamide and Dexametasone as a Salvage Regimen in Relapsed Multiple Myeloma Patients.
    Colado, Enrique
    Mateos, Maria-Victoria
    Moreno, Maria-Jose
    Dearriba, Felipe
    de la Rubia, Javier
    Lahuerta, Juan Jose
    Iniesta, Pastora
    Viguria, Maria Cruz
    Gonzalez, Ana Pilar
    Garcia-Sanz, Ramon
    Olazabal, Juan
    Miguel, Jesus F. San
    [J]. BLOOD, 2008, 112 (11) : 1265 - 1266
  • [44] Modified dose of melphalan-prednisone in multiple myeloma patients receiving bortezomib plus melphalan-prednisone treatment
    Lee, Se Ryeon
    Choi, Hojoon
    Lee, Byung Hyun
    Kang, Ka-Won
    Yu, Eun Sang
    Kim, Dae Sik
    Park, Yong
    Choi, Chul Won
    Kim, Byung Soo
    Sung, Hwa Jung
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (06): : 1333 - 1346
  • [45] Maintenance Therapy with Bortezomib Plus Thalidomide (VT) or Bortezomib Plus Prednisone (VP) In Elderly Myeloma Patients Included In the GEM2005MAS65 Spanish Randomized Trial
    Mateos, Maria-Victoria
    Oriol, Albert
    Teruel, Ana-Isabel
    Bengoechea, Enrique
    Perez, Montse
    Lopez, Javier
    Diaz-Mediavilla, Joaquin
    Mariano Hernandez, Jose
    de Arriba, Felipe
    Gonzalez, Yolanda
    Blade, Joan
    Jose Lahuerta, Juan
    San Miguel, Jesas F.
    [J]. BLOOD, 2011, 118 (21) : 222 - 222
  • [46] THE MAINTENANCE THERAPY WITH THALIDOMIDE IN ELDERLY PATIENTS WITH MULTIPLE MYELOMA
    Bila, J.
    Lekovic, D.
    Smiljanic, M.
    Sretenovic, A.
    Andjelic, B.
    Vidovic, A.
    Todorovic, M.
    Elezovic, I.
    Tomin, D.
    Gotic, M.
    Mihaljevic, B.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 583 - 583
  • [47] Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myeloma
    Palumbo, A
    Avonto, I
    Bruno, B
    Ambrosini, MT
    Bringhen, S
    Cavallo, F
    Falco, P
    Boccadoro, M
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 76 (04) : 273 - 277
  • [48] Erratum: Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant-ineligible patients with multiple myeloma: a meta-analysis
    P Kapoor
    S V Rajkumar
    A Dispenzieri
    M A Gertz
    M Q Lacy
    D Dingli
    J R Mikhael
    V Roy
    R A Kyle
    P R Greipp
    S Kumar
    S J Mandrekar
    [J]. Leukemia, 2011, 25 : 1523 - 1524
  • [49] Daratumumab, Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in TransplantIneligible Patients with Newly Diagnosed Multiple Myeloma: Pooled Analysis of Octans and Alcyone
    Hou, Jian
    Fu, Weijun
    Bang, Soo-Mee
    Huang, Honghui
    Kim, Kihyun
    Li, Wei
    An, Gang
    Lee, Je-Jung
    Cai, Zhen
    Jin, Jie
    Wang, Yafei
    Chim, C. S.
    Rodriguez-Otero, Paula
    Dimopoulos, Meletios A.
    Fujisaki, Tomoaki
    Lee, Jae Hoon
    Wroblewski, Susan
    Carson, Robin
    Qi, Ming
    Wang, Jianping
    Song, Yang
    Bin Jia
    Yang, Xue
    Liu, Wenyu
    Li, Yunan
    Zhang, Renyi
    Wang, Jianxiang
    [J]. BLOOD, 2021, 138
  • [50] Bortezomib (Velcade)-Melphalan-Prednisone (VMP) Versus Velcade-Thalidomide-Prednisone (VTP) in Elderly Untreated Multiple Myeloma Patients: Which Is the Best Partner for Velcade: An Alkylating or An Immunomodulator Agent?
    Mateos, Maria-Victoria
    Oriol, Albert
    Martinez, Joaquin
    Cibeira, M. Teresa
    de Paz, Raquel
    Terol, M. Jose
    Garcia-Larana, Jose
    Bengoechea, Enrique
    Martinez, Rafael
    Martin, Alejandro
    de Arriba, Felipe
    Palomera, Luis
    Hernandez, Jose
    Bello, Jose-Luis
    Martin, Maria-Luisa
    Gonazlez, Yolanda
    Blade, Joan
    Jose Lahuerta, Juan
    San Miguel, J. F.
    [J]. BLOOD, 2008, 112 (11) : 243 - 243
12345